[Progress in Antiretroviral Therapy and HAND].
Yusuke Matsui, Akifumi Takaori‐Kondo
Abstract
Yusuke Matsui, Akifumi Takaori‐Kondo
Abstract
Today, over 20,000 people are thought to be infected with human immunodeficiency virus (HIV) in Japan. Antiretroviral therapy (ART) has substantially improved the prognosis of HIV-infected patients, but long-term medication generates new problems. This article overviews the progress of anti-HIV therapies and explains the concept of HIV-associated neurocognitive disorders (HAND) as a noted complication of HIV infection.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Today, over 20,000 people are thought to be infected with human immunodeficiency virus (HIV) in Japan. Antiretroviral therapy (ART) has substantially improved the prognosis of HIV-infected patients, but long-term medication generates new problems. This article overviews the progress of anti-HIV therapies and explains the concept of HIV-associated neurocognitive disorders (HAND) as a noted complication of HIV infection.
Key concepts: Neurocognitive, Antiretroviral therapy, Human immunodeficiency virus (HIV), Medicine, Intensive care medicine, Complication, Virology, Immunology